ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Revolution Medicines, Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 22 studies whose lead sponsor is Revolution Medicines, Inc. or the company grouped under it. 13 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Revolution Medicines with Bristol-Myers Squibb and Eli Lilly →

Pipeline: 3 programs

Each counted once: 3 with a study Revolution Medicines, Inc. leads registered in the last two years.

  • Phase 1
  • Phase 3

The 2 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Revolution Medicines, Inc.’s own registered studies; Revolution Medicines, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Revolution Medicines, Inc.’s studies test, most open studies first — 9 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

4 of Revolution Medicines, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. 1M
  6. A
  7. 1M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 4 to your calendar (.ics) → With an account.

All 22 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1359%
  • Under way, not recruiting29%
  • Completed418%
  • Stopped early15%
  • Status unknown or other29%Approved for marketing 1 · Status unknown 1

Phase

  • Phase 112
  • Phase 28
  • Phase 37

Where

  • United States22
  • Italy10
  • Spain8
  • Korea, Republic of7
  • Germany7
  • France7

Over the years

  1. 18
  2. 19
  3. 20
  4. 21
  5. 22
  6. 23
  7. 24
  8. 25
  9. 626

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Revolution Medicines, Inc.

  • Revolution Medicines, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    20 studies
  • EQRx, Inc.
    Acquired — became part of Revolution Medicines, Inc., Nov 9, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →

Focus areas

Conditions Revolution Medicines, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 22 of 22.